vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Sezzle Inc. (SEZL). Click either name above to swap in a different company.
Sezzle Inc. is the larger business by last-quarter revenue ($135.5M vs $47.7M, roughly 2.8× IRONWOOD PHARMACEUTICALS INC). Sezzle Inc. runs the higher net margin — 37.9% vs -4.8%, a 42.6% gap on every dollar of revenue. On growth, Sezzle Inc. posted the faster year-over-year revenue change (29.2% vs -47.3%). Over the past eight quarters, Sezzle Inc.'s revenue compounded faster (111.9% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Sezzle is a publicly traded financial technology company headquartered in Minneapolis, U.S, with operations in the United States and Canada. The company provides an alternative payment platform offering interest-free installment plans at selected online stores. As of June 2021, the Sezzle platform had over 10 million user sign-ups and over 48,000 participating merchants.
IRWD vs SEZL — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $135.5M |
| Net Profit | $-2.3M | $51.3M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 50.9% |
| Net Margin | -4.8% | 37.9% |
| Revenue YoY | -47.3% | 29.2% |
| Net Profit YoY | -200.9% | 41.9% |
| EPS (diluted) | $0.01 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $135.5M | ||
| Q4 25 | $47.7M | $78.2M | ||
| Q3 25 | $122.1M | $57.5M | ||
| Q2 25 | $85.2M | $52.0M | ||
| Q1 25 | $41.1M | $48.2M | ||
| Q4 24 | $90.5M | $48.4M | ||
| Q3 24 | $91.6M | $35.6M | ||
| Q2 24 | $94.4M | $30.2M |
| Q1 26 | — | $51.3M | ||
| Q4 25 | $-2.3M | $42.7M | ||
| Q3 25 | $40.1M | $26.7M | ||
| Q2 25 | $23.6M | $27.6M | ||
| Q1 25 | $-37.4M | $36.2M | ||
| Q4 24 | $2.3M | $25.4M | ||
| Q3 24 | $3.6M | $15.4M | ||
| Q2 24 | $-860.0K | $29.7M |
| Q1 26 | — | 50.9% | ||
| Q4 25 | 14.3% | 70.6% | ||
| Q3 25 | 61.8% | 61.9% | ||
| Q2 25 | 53.2% | 69.4% | ||
| Q1 25 | -70.7% | — | ||
| Q4 24 | 34.8% | 63.8% | ||
| Q3 24 | 28.0% | 58.6% | ||
| Q2 24 | 26.5% | 55.3% |
| Q1 26 | — | 37.9% | ||
| Q4 25 | -4.8% | 54.6% | ||
| Q3 25 | 32.8% | 46.4% | ||
| Q2 25 | 27.7% | 53.1% | ||
| Q1 25 | -90.9% | 75.1% | ||
| Q4 24 | 2.5% | 52.4% | ||
| Q3 24 | 4.0% | 43.4% | ||
| Q2 24 | -0.9% | 98.4% |
| Q1 26 | — | — | ||
| Q4 25 | $0.01 | $1.19 | ||
| Q3 25 | $0.23 | $0.75 | ||
| Q2 25 | $0.14 | $0.78 | ||
| Q1 25 | $-0.23 | $1.00 | ||
| Q4 24 | $0.03 | $0.71 | ||
| Q3 24 | $0.02 | $0.44 | ||
| Q2 24 | $-0.01 | $0.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $196.7M |
| Total Assets | $396.9M | $454.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $215.5M | $64.1M | ||
| Q3 25 | $140.4M | $104.1M | ||
| Q2 25 | $92.9M | $88.9M | ||
| Q1 25 | $108.5M | $88.9M | ||
| Q4 24 | $88.6M | $73.2M | ||
| Q3 24 | $88.2M | $80.1M | ||
| Q2 24 | $105.5M | $58.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — |
| Q1 26 | — | $196.7M | ||
| Q4 25 | $-261.8M | $169.8M | ||
| Q3 25 | $-264.2M | $155.3M | ||
| Q2 25 | $-308.2M | $130.4M | ||
| Q1 25 | $-334.1M | $125.8M | ||
| Q4 24 | $-301.3M | $87.8M | ||
| Q3 24 | $-311.3M | $61.1M | ||
| Q2 24 | $-321.7M | $50.3M |
| Q1 26 | — | $454.3M | ||
| Q4 25 | $396.9M | $400.2M | ||
| Q3 25 | $396.1M | $367.0M | ||
| Q2 25 | $342.9M | $350.6M | ||
| Q1 25 | $327.2M | $298.1M | ||
| Q4 24 | $350.9M | $298.4M | ||
| Q3 24 | $389.5M | $252.9M | ||
| Q2 24 | $395.6M | $212.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | — |
| Free Cash FlowOCF − Capex | $74.6M | — |
| FCF MarginFCF / Revenue | 156.3% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $74.6M | $70.6M | ||
| Q3 25 | $47.6M | $63.7M | ||
| Q2 25 | $-15.1M | $23.1M | ||
| Q1 25 | $20.0M | $52.5M | ||
| Q4 24 | $15.2M | $57.4M | ||
| Q3 24 | $9.9M | $35.1M | ||
| Q2 24 | $33.5M | $22.2M |
| Q1 26 | — | — | ||
| Q4 25 | $74.6M | $70.6M | ||
| Q3 25 | $47.6M | $63.6M | ||
| Q2 25 | $-15.1M | $22.7M | ||
| Q1 25 | $19.9M | $52.5M | ||
| Q4 24 | — | $57.4M | ||
| Q3 24 | $9.9M | $35.1M | ||
| Q2 24 | $33.4M | $22.2M |
| Q1 26 | — | — | ||
| Q4 25 | 156.3% | 90.2% | ||
| Q3 25 | 39.0% | 110.6% | ||
| Q2 25 | -17.7% | 43.6% | ||
| Q1 25 | 48.4% | 108.9% | ||
| Q4 24 | — | 118.5% | ||
| Q3 24 | 10.8% | 98.6% | ||
| Q2 24 | 35.4% | 73.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.0% | 0.1% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.1% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.65× | ||
| Q3 25 | 1.19× | 2.39× | ||
| Q2 25 | -0.64× | 0.84× | ||
| Q1 25 | — | 1.45× | ||
| Q4 24 | 6.74× | 2.26× | ||
| Q3 24 | 2.71× | 2.27× | ||
| Q2 24 | — | 0.75× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
